Using zebrafish “Avatars”, an animal model developed by the Cancer Development and Innate Immune Evasion lab at the Champalimaud Foundation (CF), led by Rita Fior, Mayra Martínez-López – a former PhD student at the lab now working at the Universidad de las Américas in Quito, Ecuador – and colleagues studied the initial steps of the Bacillus Calmette-Guérin (BCG) vaccine’s action on bladder cancer cells.

Co-organised by Fundación CIEN, Fundación Reina Sofía, and the Champalimaud Foundation, this scientific congress aims to bring advances in research in the fight against Alzheimer's and other neurodegenerative diseases to the public, and above all, to raise awareness to advance the search for global solutions and responses due to their social consequences.

Now, Megan Carey from the Champalimaud Foundation (CF), Mónica Sousa from the Instituto de Investigação e Inovação em Saúde (i3S), Ricardo Henriques from the Instituto Gulbenkian de Ciência (IGC), and Rui Oliveira from IGC and the Instituto Universitário de Ciências Psicológicas Sociais e da Vida (ISPA), become EMBO Mem

Host

Adriana Sánchez Danés, Principal Investigator, Champalimaud Research

Venue

Seminar room

Abstract

To overcome the complexities of cancer and pave a path towards a cure, the McManus Lab is developing innovative approaches that consider both the genetic drivers of the disease and its interactions within the cellular environment. Join Dr. McManus to explore new technologies and methods to combat this multifaceted complex human disease.

Host

Adriana Sánchez Danés, Principal Investigator, Champalimaud Research

Venue

Seminar room

Host

Adriana Sánchez Danés, Principal Investigator, Champalimaud Research

Venue

Seminar room